Skip to main content
    R

    Reviva Pharmaceuticals Holdings Inc. (RVPH)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • PINK

    $0.35
    -0.04 (-9.13%)

    Market Cap: $4.63M

    Last updated: Nov 13, 2026 at 4:00 PM ET

    Reviva Pharmaceuticals Holdings Inc. (RVPH) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Sep 30, 2026, Reviva Pharmaceuticals Holdings reported EPS of -$0.17, above the -$0.18 estimate. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    46%(11/24)
    Avg Surprise
    -19.95%
    Streak
    2 Q

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$0.74
    Range-$1.37 - -$0.10
    8 analysts
    Revenue Consensus
    N/A
    RangeN/A
    5 analysts

    Next Report

    RVPH's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.

    Earnings History

    Of the 24 quarters below that had an estimate, RVPH beat 11, missed 9 and matched 4. The widest gap in the table came in the quarter ended Dec 31, 2024, when EPS landed 300.00% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.17-$0.18-$0.18 - -$0.18+5.56%BeatN/A11 up, 0 downNov 12, 2026
    Jun 30, 2026-$0.19-$0.41-$0.41 - -$0.41+53.66%BeatN/A10 up, 1 downAug 12, 2026
    Mar 31, 2026-$0.46-$0.29-$0.29 - -$0.29-58.62%MissN/A22 up, 0 downMay 14, 2026
    Dec 31, 2025-$5.19-$0.07N/AN/AN/AN/A61 up, 0 downMar 30, 2026
    Sep 30, 2025-$1.20-$1.94-$2.60 - -$0.80+38.14%BeatN/A71 up, 0 downNov 13, 2025
    Jun 30, 2025-$2.40-$2.20-$2.80 - -$1.60-9.09%MissN/A42 up, 0 downAug 14, 2025
    Mar 31, 2025-$2.60-$3.65-$4.00 - -$3.40+28.77%BeatN/A43 up, 0 downMay 15, 2025
    Dec 31, 2024-$0.90-$0.23-$0.25 - -$0.19-300.00%MissN/A50 up, 0 downMar 31, 2025
    Sep 30, 2024-$5.00-$5.00-$6.20 - -$4.000.00%In lineN/A42 up, 0 downNov 14, 2024
    Jun 30, 2024-$5.20-$6.20-$6.20 - -$5.40+16.13%BeatN/A40 up, 0 downAug 14, 2024
    Mar 31, 2024-$5.00-$7.53-$9.20 - -$5.60+33.60%BeatN/A31 up, 0 downApr 15, 2024
    Dec 31, 2023-$0.35-$0.35-$0.38 - -$0.290.00%In lineN/A40 up, 0 downMar 19, 2024
    Sep 30, 2023-$8.80-$7.75-$10.60 - -$5.00-13.55%MissN/A50 up, 0 downNov 14, 2023
    Jun 30, 2023-$11.00-$5.00-$6.80 - -$4.40-120.00%MissN/A50 up, 0 downAug 14, 2023
    Mar 31, 2023-$6.00-$5.80-$7.20 - -$5.80-3.45%MissN/A20 up, 0 downMay 15, 2023
    Dec 31, 2022-$0.38-$0.22-$0.27 - -$0.19-72.73%MissN/A40 up, 0 downMar 30, 2023
    Sep 30, 2022-$3.60-$5.20-$6.00 - -$5.20+30.77%BeatN/A30 up, 0 downNov 14, 2022
    Jun 30, 2022-$5.80-$7.00N/A+17.14%BeatN/AN/A0 up, 0 downAug 15, 2022
    Mar 31, 2022-$8.00-$5.00N/A-60.00%MissN/A10 up, 0 downMay 16, 2022
    Dec 31, 2021-$0.22-$0.25-$0.27 - -$0.22+12.00%BeatN/A31 up, 0 downMar 15, 2022
    Sep 30, 2021-$2.40-$4.60-$5.00 - -$4.40+47.83%BeatN/A20 up, 0 downNov 15, 2021
    Jun 30, 2021-$2.40-$4.80N/A+50.00%BeatN/AN/AN/AAug 16, 2021
    Mar 31, 2021-$0.10-$0.10N/A0.00%In lineN/AN/AN/AMay 17, 2021
    Dec 31, 2020-$3.30-$1.20N/A-175.00%Miss-6700.0%N/AN/AMar 22, 2021
    Sep 30, 2020-$0.04-$0.04N/A0.00%In line-136.4%N/AN/ADec 2, 2020
    Jun 30, 2020-$0.06N/AN/AN/AN/A-146.2%N/AN/AJul 7, 2020
    Mar 31, 2020-$0.05N/AN/AN/AN/A-101.9%N/AN/AMay 1, 2020
    Dec 31, 2019$0.05N/AN/AN/AN/A-93.3%N/AN/AJan 10, 2020
    Sep 30, 2019$0.11N/AN/AN/AN/A-94.6%N/AN/AOct 8, 2019
    Jun 30, 2019$0.13N/AN/AN/AN/AN/AN/AN/AJul 3, 2019
    Mar 31, 2019$2.60N/AN/AN/AN/AN/AN/AN/AMay 22, 2019
    Dec 31, 2018$0.74N/AN/AN/AN/AN/AN/AN/AJan 9, 2019
    Sep 30, 2018$2.03N/AN/AN/AN/AN/AN/AN/AOct 11, 2018
    Last 33 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$11.39, after -$16.10 the year before. It was $2.77 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$11.39N/A
    Dec 31, 2024-$16.10N/A
    Dec 31, 2023-$26.15N/A
    Dec 31, 2022-$17.78N/A
    Dec 31, 2021-$5.12N/A
    Dec 31, 2020-$3.45-219.3%
    Dec 31, 2019$2.89+4.4%
    Dec 31, 2018$2.77N/A

    Frequently Asked Questions About RVPH

    Did RVPH beat earnings estimates last quarter?

    Yes. Reviva Pharmaceuticals Holdings reported EPS of -$0.17 for the quarter ended Sep 30, 2026, above the -$0.18 estimate, a 5.56% surprise.

    What EPS do analysts expect from RVPH next quarter?

    The consensus EPS estimate for Reviva Pharmaceuticals Holdings for the quarter ending Dec 31, 2026 is -$0.74 from 8 analysts, with estimates from -$1.37 to -$0.10.

    How often does RVPH beat earnings estimates?

    Reviva Pharmaceuticals Holdings beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of -30.20%.